RedHill Biopharma Ratios (2011-2025) | RDHL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Dec2023	Jun2024	Dec2024	Jun2025	Dec2025
Profitability
Gross Margin (Quarter)	50.44%	-62.41%	32.11%	50.64%	50.37%	50.17%	50.75%	57.29%	12.40%	51.98%	50.97%	46.15%	32.82%	55.21%	55.12%
EBT Margin (Quarter)	744.47%	1,557.48%	42.84%	49.10%	70.29%	65.33%	96.04%	62.05%	-658.08%	97.15%	36.01%	-122.41%	-543.22%	-220.03%	3,280.68%
EBIT Margin (Quarter)	739.87%	1,611.36%	59.81%	69.04%	91.83%	88.22%	115.74%	80.51%	-641.43%	126.90%	49.92%	40.50%	-591.81%	-808.00%	2,992.87%
EBITDA Margin (Quarter)	739.87%	1,624.72%	76.78%	88.99%	91.83%	111.12%	135.43%	98.97%	-641.43%	130.78%	63.83%	203.40%	-591.81%	-808.00%	2,992.87%
Operating Margin (Quarter)	739.87%	1,611.36%	59.81%	69.04%	91.83%	88.22%	115.74%	80.51%	-641.43%	126.90%	49.92%	40.50%	-591.81%	-808.00%	2,992.87%
Net Margin (Quarter)	744.47%	1,557.48%	42.84%	49.10%	70.29%	65.33%	96.04%	62.05%	-658.08%	97.15%	36.01%	-122.41%	-543.22%	-220.03%	3,280.68%
FCF Margin (Quarter)	-870.19%	-983.14%	-71.82%	-43.00%	-58.97%	-59.19%	-87.88%	-87.94%	-67.31%	-31.61%	-89.49%	-34.22%	-18.92%
Efficiency
Inventory Average (Quarter)	1.92M	2.32M	3.76M	4.92M	5.81M	7.90M	9.02M	10.94M	10.41M	10.99M	13.00M	12.15M	11.80M	8.43M	5.40M	4.66M	4.10M	3.73M	3.41M
Assets Average (Quarter)	57.17M	108.79M	154.93M	167.68M	174.61M	200.18M	211.90M	195.00M	183.76M	174.12M	167.51M	162.58M	158.03M	108.85M	46.94M	29.04M	22.54M	20.03M	18.21M	21.86M
Equity Average (Quarter)																			-4.55M	-0.07M
Invested Capital (Quarter)	63.82M	78.17M	79.19M	80.27M	19.38M	82.52M	83.16M	83.52M	29.36M	86.40M	85.51M	113.86M	-37.24M			3.24M		7.33M	-4.41M	19.04M
Asset Utilization Ratio (Quarter)	0.11	0.05	0.16	0.27	0.37	0.42	0.40	0.44	0.47	0.45	0.45	0.44	0.39	0.48	0.76
Leverage & Solvency
Interest Coverage Ratio (Quarter)	62.91	47.93	3.42	3.43	4.33	3.82	5.86	4.34	-38.41	4.25	2.17	0.22	-30.53	-69.07	27.91
Debt to Equity (Quarter)					11.74				18.84				-2.38
Debt Ratio (Quarter)		0.54	0.48	0.48	0.90	0.37	0.41	0.45	0.92	0.52	0.51	0.72	0.73
Equity Ratio (Quarter)	0.81				0.08				0.05				-0.30			0.09		-0.26	-0.24	0.17
Times Interest Earned (Quarter)	62.91	47.93	3.42	3.43	4.33	3.82	5.86	4.34	-38.41	4.25	2.17	0.22	-30.53	-69.07	27.91
Valuation
Enterprise Value (Quarter)	-37.52M	-35.22M	-86.13M	-28.61M	-29.78M	-75.97M	-51.82M	-23.25M	-29.47M	-28.85M	-33.06M	-32.41M	-22.59M	-19.20M	-8.63M	-6.31M	-9.82M	-6.04M	-4.63M	-3.97M
Return Ratios
Return on Sales (Quarter)	0.07%	0.16%	0.00%	0.00%	0.01%	0.01%	0.01%	0.01%	-0.07%	0.01%	0.00%	-0.01%	-0.05%	-0.02%	0.33%
Return on Capital Employed (Quarter)	92.79%		42.94%		62.82%		58.17%		-79.32%		-9,001.37%		108.68%		-234.47%
Return on Assets (Quarter)	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	-0.01%	-0.01%	-0.01%	0.02%	0.03%
Return on Equity (Quarter)

Research Tools

RedHill Biopharma Ratios (2011-2025) | RDHL

Create an account

Sign In

Reset Password